Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

The point of care lipid test market is gaining momentum as healthcare providers focus on quicker, more accessible lipid screening methods. With cardiovascular diseases on the rise, the demand for efficient testing solutions is increasing across various healthcare settings. Let’s explore the current market size, key growth drivers, leading players, and emerging trends shaping this field.

Market Size and Expected Growth Trajectory in the Point of Care Lipid Test Market

The point of care lipid test market has experienced significant expansion in recent years. It is projected to grow from $0.74 billion in 2025 to $0.82 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.7%. This historical growth is largely due to the rising prevalence of cardiovascular diseases, the need for prompt testing, advancements in biosensor technology, heightened awareness about cholesterol control, and increased availability of point-of-care devices. Looking ahead, the market is anticipated to reach $1.17 billion by 2030 with a CAGR of 9.4%. Factors fueling this future growth include the integration of mobile applications and cloud-based platforms, greater adoption in home care environments, expansion in clinics and hospitals, the development of multi-analyte testing capabilities, and strategic partnerships between device manufacturers and software providers. Emerging trends set to influence the market include fingerstick lipid testing, handheld analyzers, multi-parameter devices, rapid cardiovascular risk assessments, and home-based lipid monitoring solutions.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28300&type=smp

Rising Cardiovascular Disease Rates Boost Demand for Point of Care Lipid Tests

One of the primary factors driving the point of care lipid test market is the increasing incidence of cardiovascular diseases globally. These conditions—such as coronary artery disease, stroke, and hypertension—are often linked to abnormal cholesterol and triglyceride levels caused by atherosclerosis. Lifestyle changes including sedentary behavior and lack of physical activity contribute significantly to obesity, poor circulation, and other cardiovascular risk factors. Point-of-care lipid testing plays a crucial role by enabling quick, onsite measurement of lipids, facilitating early detection of risk and allowing timely treatment decisions to prevent disease progression. For instance, in January 2024, the American Heart Association reported 931,578 cardiovascular disease-related deaths in the US, an increase of 3,000 compared to the previous year, underscoring the urgency of improved lipid management and testing solutions.

How Continued Advances in Medical Technology are Enhancing Market Growth

Technological innovation is another key contributor to the market’s upward trend. Improvements in biosensor technology have made point-of-care lipid tests more accurate, reliable, and user-friendly. The shift towards portable devices enables healthcare professionals and patients to monitor lipid levels conveniently outside traditional lab settings, supporting faster clinical decisions and better patient outcomes.

Access The Complete Point Of Care Lipid Test Market Report:

https://www.thebusinessresearchcompany.com/report/point-of-care-lipid-test-global-market-report

Expanding Use Across Different Healthcare Settings Further Supports Market Expansion

Moreover, the rising adoption of point-of-care lipid testing in diverse settings—such as hospitals, clinics, and home care environments—is broadening the market reach. This expansion is driven by the need for accessible, rapid testing, especially in remote or resource-limited areas where conventional laboratory testing is less feasible.

Comprehensive Market Segmentation in Point of Care Lipid Testing

This report segments the point of care lipid test market into several categories:

By product type, the market includes instruments and consumables.

By application, it covers hyperlipidemia, hypertriglyceridemia, hyperlipoproteinemia, familial hypercholesterolemia, and other conditions.

By end-user, the segments are hospitals, clinics, home care settings, and other users.

Further detailed breakdowns comprise instrument types such as portable or handheld analyzers, multi-parameter analyzers, and single-parameter analyzers, along with consumables like test strips, reagents, and kits.

Key Market Trends Shaping Innovation and Competition

The point of care lipid test market is witnessing notable competition driven by the development of advanced diagnostic platforms. These portable, integrated devices deliver rapid, lab-quality lipid panel results at the patient’s bedside, enhancing clinical decision-making and care personalization. For example, in July 2023, Vital Biosciences Inc., a Canadian health technology firm, introduced VitalOne—a point-of-care testing platform capable of providing over 50 lab-grade blood test outcomes within 20 minutes. This compact system combines hematology, clinical chemistry, and immunoassays in a single device, enabling testing, diagnosis, and treatment in one visit, significantly improving access, speed, and accuracy compared to traditional labs.

Leading Corporations Driving the Point of Care Lipid Test Market

Prominent companies steering this market include Abbott Laboratories, EKF Diagnostics Holdings plc, Roche Diagnostics International AG, Siemens Healthineers AG, Horiba ABX SAS, Randox Laboratories Ltd., Sekisui Diagnostics LLC, EKF Diagnostics USA Inc., VivaChek Biotech (Hangzhou) Co. Ltd., Menarini Diagnostics S.r.l., Trinity Biotech plc, AccuBioTech Co. Ltd., MiCo BioMed Co. Ltd., BHR Diagnostics Private Limited, SD Biosensor Inc., ARKRAY Inc., PTS Diagnostics, HemoCue AB, MedTest Dx Inc., and Nova Biomedical Corporation.

Regional Market Overview Highlighting Areas of Rapid Growth

In 2025, North America held the largest share of the point of care lipid test market. However, the Asia-Pacific region is set to experience the fastest growth over the forecast period. Other key regions covered include South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a broad perspective on global market dynamics.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model